Replies to post #324033 on $Stock*Shop*Charts*News*Option$

[Tuff-Stuff]

The SEC is looking into whether generic-drug maker Mylan (MYL) improperly disclosed confidential earnings data to several analysts and investors in a Sept. 2009 meeting, prompting a 7% rise in its stock the next day on three times as much volume as usual.